Updated June 6, 2014
A study led by Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, is the first to trace in real-time how the drug telaprevir inhibits viral replication in the liver and how it clears hepatitis C virus from infected cells and plasma.
